J. Leibovici

发表

Sensitivity to macrophages decreases with tumor progression in the AKR lymphoma.

J. Hiss, T. Kaptzan, E. Skutelsky, 2000, Advances in experimental medicine and biology.

Release from apoptosis correlates with tumor progression in the AKR lymphoma.

J. Hiss, M. Michowitz, S. Kay, 2000, Biochimica et biophysica acta.

Comparison of growth rate of two B16 melanomas differing in metastatic potential in young versus middle-aged mice.

A. Staroselsky, J. Leibovici, J. Nordenberg, 1997, Cancer investigation.

M. Huszar, A. Staroselsky, J. Leibovici, 1996, Cancer letters.

Apoptosis and Cell Proliferation Capacity in AKR Lymphoma Malignancy Variants

M. Michowitz, A. Siegal, S. Kay, 2000, Cancer investigation.

Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan

A. Siegal, J. Leibovici, S. Kopel, 2004, Cell and Tissue Research.

Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.

H. Yavetz, A. Siegal, J. Leibovici, 1989, International journal of immunopharmacology.

Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.

M. Wolman, J. Leibovici, Y. Stark, 1983, British journal of experimental pathology.

Effect of administration schedule on the levan-cyclophosphamide combined treatment of Lewis lung carcinoma.

M. Wolman, J. Leibovici, Y. Stark, 1983, International journal of immunopharmacology.

Mechanism of the inhibitory effect of levan on experimental tumors.

M. Wolman, J. Leibovici, Y. Stark, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Ageing–apoptosis relation in murine spleen

M. Huszar, T. Kaptzan, E. Skutelsky, 2003, Mechanisms of Ageing and Development.

Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines

J. Leibovici, Y. Wollman, I. Shahar, 2005, Journal of Neuro-Oncology.

Apoptotic cell death and related gene expression in metastatic tumors of AKR lymphomas of varying malignancy

M. Michowitz, A. Siegal, S. Kay, 1999, Apoptosis.

Designing ageing conditions in tumour microenvironment—A new possible modality for cancer treatment

M. Huszar, T. Kaptzan, E. Skutelsky, 2009, Mechanisms of Ageing and Development.

Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems.

M. Michowitz, J. Leibovici, N. Donin, 1995, International journal of experimental pathology.

Antitumoral activity of an immunomodulatory fraction of Nocardia opaca: mechanism of action.

S. Hoenig, J. Leibovici, A. Pinchassov, 1994, International journal of immunopharmacology.

Cell membrane fluidity and adriamycin retention in a tumor progression model of AKR lymphoma.

M. Shinitzky, J. Leibovici, Y. Wollman, 1996, Biochimica et biophysica acta.

Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged mice

M. Huszar, T. Kaptzan, E. Skutelsky, 2008, Experimental Gerontology.

Successful contact sensitization to chromate in mice.

S. Ben-Efraim, J. Leibovici, A. Ben-David, 1988, International archives of allergy and applied immunology.

Effect of hyperthermia and thermochemotherapy on primary and metastatic tumour cells of AKR lymphoma.

A. Siegal, J. Leibovici, G. Klorin, 1990, International journal of experimental pathology.

Increase in cell permeability to a cytotoxic agent by the polysaccharide levan.

J. Leibovici, Y. Stark, 1985, Cellular and molecular biology.

Histological criteria for immunological rejection of mouse skin homografts

M. Wolman, I. Bleiberg, J. Leibovici, 1977, The Journal of pathology.

Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.

J. Leibovici, Y. Stark, 1986, British journal of experimental pathology.

Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.

M. Wolman, J. Leibovici, G. Susskind-Brudner, 1980, Journal of the National Cancer Institute.

Correlation between malignancy level of AKR lymphoma variants and sensitivity to hyperthermia.

M. Michowitz, J. Leibovici, G. Klorin, 1995, Cancer biotherapy.

Apoptosis, cell proliferation and in vivo biological behaviour of primary and metastatic tumour cells of an AKR lymphoma variant

J. Hiss, M. Michowitz, S. Kay, 2004, Apoptosis.

Effect of Hyperthermia on AKR Lymphoma Variants Differing in Degree of Malignancy

Y. Sharabi, J. Leibovici, G. Klorin, 2001, Cancer investigation.

Modification of the tuberculin reaction by levan.

M. Wolman, E. Shezen, J. Leibovici, 1978, British journal of experimental pathology.

Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice.

M. Wolman, J. Leibovici, G. Davidai, 1975, Cancer research.

Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains

E. Skutelsky, M. Michowitz, O. Itzhaki, 2004, Experimental Gerontology.

Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.

J. Leibovici, Y. Stark, 1984, Journal of the National Cancer Institute.

Different biological behavior of AKR lymphoma cells from primary and metastatic tumors

J. Leibovici, Y. Stark, S. Kopel, 1985, Experientia.

Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the aged.

M. Huszar, T. Kaptzan, E. Skutelsky, 2004, Biochimica et biophysica acta.

Macrophage-recognized molecules of apoptotic cells are expressed at higher levels in AKR lymphoma of aged as compared to young mice.

M. Huszar, T. Kaptzan, E. Skutelsky, 2000, Advances in experimental medicine and biology.

In vitro effect of levan-activated macrophages on Lewis lung carcinoma cells.

S. Hoenig, J. Leibovici, A. Pinchassov, 1986, International journal of immunopharmacology.

The tumor microenvironment: part 1.

M. Huszar, O. Itzhaki, J. Leibovici, 2011, Immunotherapy.

Targeting the tumor microenvironment by immunotherapy: part 2.

M. Huszar, O. Itzhaki, J. Leibovici, 2011, Immunotherapy.

The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.

M. Wolman, J. Leibovici, A. Borit, 1979, British Journal of Cancer.

Efficacy of anti-angiogenic treatment of tumors in old versus young mice

M. Huszar, T. Kaptzan, E. Skutelsky, 2006, Mechanisms of Ageing and Development.

Biological behavior and cell properties of new AKR lymphoma malignancy variants.

M. Huszar, J. Hiss, A. Staroselsky, 1998, Tissue & cell.

Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma

J. Hiss, M. Michowitz, J. Leibovici, 1995, Mechanisms of Ageing and Development.

Differential metastatic capacity of three AKR lymphoma variants.

M. Michowitz, J. Leibovici, G. Klorin, 1992, International journal of experimental pathology (Print).

A model for cancer treatment in advanced compared to early cancer.

M. Michowitz, S. Hoenig, J. Leibovici, 1986, Anticancer Research.

Animal models for tumor progression (short review).

M. Wolman, J. Leibovici, 1984, Anticancer Research.

Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.

J. Leibovici, 1984, Cancer Research.

A model for the study of the long duration pathogenesis of cancer and its relevance to therapy.

J. Leibovici, 1983, Medical hypotheses.

Sensitivity to thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy

M. Huszar, M. Michowitz, S. Hoenig, 2004, Clinical & Experimental Metastasis.

Differential sensitivity to hyperthermia of the F1 and F10 B16 melanoma variants.

M. Huszar, M. Michowitz, S. Hoenig, 1991, International journal of experimental pathology.

AKR lymphoma malignancy variants differing at late phase of metastasis.

Y. Sharabi, M. Michowitz, A. Siegal, 1990, Cancer letters.

Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma.

M. Wolman, J. Leibovici, Y. Sinai, 1976, Cancer research.

Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.

O. Gal-Mor, A. Siegal, J. Leibovici, 1986, International journal of immunopharmacology.

Inhibitory effeft of oxidized spermine on the multiplication of coliphage T5.

U. Bachrach, J. Leibovici, 1966, Journal of molecular biology.

MECHANISM OF BACTERIOPHAGE INACTIVATION BY OXIDIZED SPERMINE.

U. Bachrach, J. Leibovici, 1965, Biochemical and biophysical research communications.

Enhancing effect of ATP on intracellular adriamycin penetration in human ovarian cancer cell lines.

M. Cohen-Armon, B. Bar-Shira Maymon, J. Leibovici, 1994, Biochimica et Biophysica Acta.

Effect of a membrane-active agent on uptake of adriamycin in Lewis lung carcinoma cells derived from 'primary' and 'metastatic' growths.

M. Michowitz, J. Leibovici, O. Klein, 1992, Chemotherapy.

Combined effect in vitro of chemotherapy with agents acting on the cell membrane of Lewis lung carcinoma.

A. Siegal, S. Hoenig, J. Leibovici, 1990, Chemotherapy.

Suppression of humoral immune response in mice by administration of high molecular levan

S. Hoenig, J. Leibovici, I. Katzap, 1978, Experientia.

Effect of lectins on tumorigenicity of AKR lymphoma cells of varying malignancy.

J. Leibovici, N. Gilboa-Garber, D. Avichezer, 1986, Anticancer research.

Histological study of homografts showing delayed rejection following levan administration

M. Wolman, I. Bleiberg, J. Leibovici, 1978, The Journal of pathology.

Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide.

M. Michowitz, J. Leibovici, Y. Stark, 1984, Cancer letters.

Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro.

J. Leibovici, Y. Stark, 1986, Chemico-biological interactions.